Ceralasertib (AZD6738)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ceralasertib (AZD6738), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer [Phase 3]